SONOMA PHARMACEUTICALS, INC. Sales Revenue, Services, Other (Deprecated 2018-01-31)
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Sales Revenue, Services, Other (Deprecated 2018-01-31) of $869.00 thousand for the 12-month period ending 2013-03-31, per its 10-K filed 2013-06-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesGross · last filed 2013-06-25
- SONOMA PHARMACEUTICALS, INC. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $189.00K, a 3.08% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $183.00K, a 5.18% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $262.00K, a 4.03% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $235.00K.
- SONOMA PHARMACEUTICALS, INC. sales revenue, services, other (deprecated 2018-01-31) for fiscal 2013 was $869.00K, a 2.47% decline from fiscal 2012.
- SONOMA PHARMACEUTICALS, INC. sales revenue, services, other (deprecated 2018-01-31) for fiscal 2012 was $891.00K.
| Period end | Sales Revenue, Services, Other (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $372.00K derived: sum of 2 quarters · filed 2013-06-25 | $634.00K derived: sum of 3 quarters · filed 2013-06-25 | $869.00K 10-K · filed 2013-06-25 |
| 2012-12-31 | $183.00K 10-Q · filed 2013-02-13 | $445.00K derived: sum of 2 quarters · filed 2013-02-13 | $680.00K 10-Q · filed 2013-02-13 | $875.00K derived: sum of 4 quarters · filed 2013-06-25 |
| 2012-09-30 | $262.00K 10-Q · filed 2012-11-08 | $497.00K 10-Q · filed 2012-11-08 | $692.00K derived: sum of 3 quarters · filed 2013-06-25 | $885.00K derived: sum of 4 quarters · filed 2013-06-25 |
| 2012-06-30 | $235.00K derived: 10-K 12 month − 3 quarters · filed 2013-06-25 | $430.00K derived: sum of 2 quarters · filed 2013-06-25 | $623.00K derived: sum of 3 quarters · filed 2013-06-25 | $896.00K derived: sum of 4 quarters · filed 2013-06-25 |
| 2012-03-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $388.00K derived: sum of 2 quarters · filed 2013-06-25 | $661.00K derived: sum of 3 quarters · filed 2013-06-25 | $891.00K 10-K · filed 2013-06-25 |
| 2011-12-31 | $193.00K 10-Q · filed 2013-02-13 | $466.00K derived: sum of 2 quarters · filed 2013-02-13 | $696.00K 10-Q · filed 2013-02-13 | |
| 2011-09-30 | $273.00K 10-Q · filed 2012-11-08 | $503.00K 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |